If I was MYX, I would consider making a tilt for pharmaxis (also asx listed). Their market cap is currently under 50 million and they have complementary products under patent that can be added to the portfolio under dev. Ie burn creams and innovative respiratory therapies, You can than package the company nicely, utilise the the manufacturing centre in Sth Australia and use the global distribution network to promote….
you then make Mayne a strategic attractive player with low debt, strong pipelines of growth….and attractive as a target for big pharma…
the some of the whole would be greater together.
If I was MYX, I would consider making a tilt for pharmaxis (also...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.40 |
Change
0.140(3.29%) |
Mkt cap ! $374.3M | |||
| Open | High | Low | Value | Volume |
| $4.25 | $4.43 | $4.25 | $618.9K | 141.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2957 | $4.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.41 | 968 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |